T113a : Ovary cancer test tissue array with normal ovary tissue, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases/24 cores, replaced by T113b
  • $40.00
Microarray Panel Ovarian carcinoma test tissue microarray with normal ovary tissue, containing 1 case of ovary clear cell carcinoma, 1 each of ovary adenocarcinoma, squamous cell carcinoma and transitional cell carcinoma, plus 2 normal ovary tissue, quadruple cores per case, 2 serial sections, divided into two identical 12 core arrays for testing different antibody dilutions
Cores 24
Biomax.com Tissue Array T113a
Cases 6
Row number 3
Column number 8
Core Diameter (mm) 1.5
Thickness (µm) 5
IHC1 Anti-Actin confirmed
Tissue Array Type FFPE
Species Human
Applications Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Notes 1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning. 2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.
Mouseover and click individual cores to view high resolution images.
Slide Label: US Biomax, Inc. Tissue Array
12345678 
AOvaOvaOvaOvaOvaOvaOvaOva 
BOvaOvaOvaOvaOvaOvaOvaOva 
COvaOvaOvaOvaOvaOvaOvaOvaMarked point
Legend: Ova - Ovary

- Malignant tumor, - Malignant tumor (stage IIIc), - Malignant tumor (stage IV), - Malignant tumor (stage Ia), - Normal tissue

Specification Sheet (Sortable), tissue IDs are available in exported Excel files.

TNM and FIGO classification, staging of tumors of the ovary, fallopian tube and primary peritoneal carcinoma:
TNM Primary tumor (T) and FIGO stages in ( )
• TX: Primary tumor cannot be assessed
• T0: No evidence of primary tumor
• T1(I): Tumor limited to the ovaries
• T1a(IA): Tumor limited to one ovary (capsule intact) or fallopian tube surface; no malignant cells in ascites or peritoneal washings
• T1b(IB): Tumor limited to one or
both ovaries (capsules intact) or fallopian tubes; no tumor on ovarian or fallopian tube surface, no malignant cells in ascites or peritoneal washings
• T1c(IC): Tumor limited to one or both ovaries or fallopian tubes with any of following:
• T2a(IIA): Extension and/or implants on uterus and/or fallopian tubes and/or ovaries; no malignant cells in ascites or peritoneal washings
• T2b(IIB): Extension to other pelvic intraperitoneal tissues
• T3(III): Tumor involves one or both ovaries or fallopian tubes, or primary and/or peritoneal cancer, with cytologically or histologically confirmed
• T3a(IIIA): Microscopic extrapelvic (above the pelvic brim) peritoneal involvement with or without positive retroperitoneal lymph nodes
• T3b(IIIB): Macroscopic peritoneal metastasis beyond pelvis up to 2 cm in greatest dimension or less in greatest dimension with or without retroperitoneal lymph node metastasis
• T3c(IIIC): Macroscopic peritoneal metastasis beyond pelvis more than 2 cm in greatest dimension with or without retroperitoneal lymph node metastasis (excludes extension of tumor to capsule of liver and spleen without parenchymal involvement of either organ
TRegional lymph nodes (N) and FIGO stages in ( )
• NX: Regional lymph nodes cannot be assessed
• N0: No regional lymph node metastasis
• N1 (IIIC): Regional lymph node metastasis
TDistant metastasis (M) and FIGO stages in ( )
• M0: No distant metastasis
• M1 (IV): Distant metastasis

Find overlapping cases with this tissue array:
 

Write a review

Please login or register to review

Tags: Stage (TNM), With normal control (), Test arrays